Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2016

Segment Reporting

Schedule of financial information by reporting segment

	Three Months Ended
	March 31,
	2016		2015
	(in thousands)
Net revenues:
Finished pharmaceutical products	$	58,554	$	50,872
API		812		6,014
Total net revenues		59,366		56,886
Gross Profit:
Finished pharmaceutical products		25,824		12,853
API		(922)		427
Total gross profit		24,902		13,280
Operating expenses		20,827		20,541
Income (loss) from operations		4,075		(7,261)
Non-operating income (expenses)		(259)		1,064
Income (loss) before income taxes	$	3,816	$	(6,197)

Schedule of net revenues and long-lived assets by geographic region

	Net Revenue				Long-Lived Assets
	Three Months Ended
	March 31,				March 31,		December 31,
	2016		2015		2016		2015
	(in thousands)
U.S.	$	58,538	$	52,960	$	100,290	$	100,404
China		—		—		30,739		28,547
France		828		3,926		13,655		13,210
Total	$	59,366	$	56,886	$	144,684	$	142,161